<DOC>
	<DOCNO>NCT02138461</DOCNO>
	<brief_summary>This study examine patient perception regard tolerability two class glaucoma medication : bimatoprost latanoprost .</brief_summary>
	<brief_title>Tolerability Bimatoprost 0.01 % v Latanoprost Eye Drops</brief_title>
	<detailed_description>Patients enrol study complete validated survey instrument ( COMTOL ) examine tolerability topically apply ophthalmic medication already take regular course care glaucoma . The purpose study determine whether side effect symptoms drug already take cause problem activity daily live .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Patients glaucoma take either bimatoprost latanoprost patient take medication cause ocular surface symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>bimatoprost</keyword>
	<keyword>latanoprost</keyword>
	<keyword>tolerability</keyword>
</DOC>